Phase I study of <scp>OPB</scp>‐51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies
Michinori Ogura(Japanese Red Cross Nagoya Daini Hospital), Kiyohiko Hatake(Japanese Foundation For Cancer Research)
Cited by 101
Related Papers
No related papers found
Powered by citation graph analysis